截至2025年中报，药明康德营业总收入207.99亿元、净利润82.87亿元。 本文源自：金融界 作者：行情君 7月31日，药明康德(02359)盘中下跌5.89%，截至09:30，报105.4元/股，成交9276.73万元。 无锡药明康德新药开发股份有限公司主要提供一体化的新药研发和生产服务，致力于推动全球医药健康 创新。公司通过"CRDMO"业务模式，服务来自全球30多个国家的约6,000家合作伙伴，助力提升研发效 率，推动新药研发成果落地。 ...

Market Overview - The A-share market opened with the Shanghai Composite Index down by 0.3%, while the Shenzhen Component Index increased by 0.05%, and the ChiNext Index rose by 0.65% [1] Sector Performance - The CPO (Consumer Packaged Goods) concept saw a strong opening, with companies like Dongshan Precision, Zhongji Xuchuang, and Shengyi Electronics rising over 5% [1] - The assisted reproductive technology sector was active, with Lide Man and Hanshang Group hitting the daily limit, as all 31 provinces in China included assisted reproductive technology in medical insurance [1] - The non-ferrous metals sector experienced a broad decline, with Hunan Silver and Northern Copper falling over 3% [1] - The military equipment sector opened lower, with Guorui Technology dropping over 8% and Construction Industry falling nearly 6% [1]

7月24日，由国家卫生健康委医政司指导、中国医学科学院阜外医院主办的第四十期"阜外心血管技术协 作大讨论"以线上+线下形式在互联网上召开。山东大学齐鲁医院德州医院作为国家区域医疗中心建设 单位，依托互联网医院5G远程会诊中心首次实现与阜外医院跨区域实时病例研讨，完成主动脉夹层云 端MDT首秀。山东大学齐鲁医院德州医院心血管专业赵鹏教授、血管外科王海庆教授、心脏外科李建 新教授及科室业务骨干在线参会，与阜外医院血管中心罗晓尧、高伟教授团队，云南省阜外心血管病医 院心外科张恒教授，围绕复杂冠心病介入策略、Stanford A型主动脉夹层术后管理等热点议题展开深度 交流。 血管外科副主任医师闫文科汇报《一例复杂主动脉夹层诊疗思考》疑难杂症案例，患者为48岁男性，突 发胸背痛10小时入院，CTA提示Stanford A型夹层累及主动脉根部。山东大学齐鲁医院德州医院医疗团 队即刻上传患者高分辨率CTA、三维重建、术中TEE及实验室数据。阜外专家结合2024 ESC《主动脉疾 病管理指南》最新循证证据，就夹层分型、手术时机、脑保护策略及抗栓方案进行30分钟精准点评，最 终形成"分期TEVAR+根部重建"的个体化路径，并同 ...

融券方面，当日融券卖出0.91万股，净卖出0.81万股。 来源：金融界 7月30日，沪深两融数据显示，通策医疗获融资买入额1.35亿元，居两市第141位，当日融资偿还额1.46 亿元，净卖出1066.35万元。 最近三个交易日，28日-30日，通策医疗分别获融资买入1.05亿元、1.42亿元、1.35亿元。 ...

长江商报消息 华康洁净（301235.SZ）29日晚间发布2025年度半年报，公司2025年上半年营业收入为 8.35亿元，同比增长50.73%；归母净利润为1868.30万元，同比扭亏、增长273.48%。同时，华康洁净公 布了2025年限制性股票激励计划，拟授予激励对象的限制性股票数量为523.58万股，涉及的激励对象共 计204人。 2025年半年报显示，华康洁净营业收入为8.35亿元，同比增长50.73%；归母净利润为1868.30万元，同 比增长273.48%；扣非归母净利润为1959.51万元，同比增长216.16%；基本每股收益0.19元；净利率为 2.40%，较上年同期上升4.34个百分点。 华康洁净称，2024年公司电子洁净订单实现"零突破"，2025年上半年，公司营业收入主要来自于净化系 统集成业务和医疗耗材销售，共交付了22个项目。至2025年6月底，公司在手订单总额38.27亿元，主要 为净化集成业务订单，其中医疗专项订单为25.37亿元，实验室订单为7.74亿元，电子洁净订单为1.21亿 元。 拟推限制性股票激励计划 在发布2025年半年报的同时，华康洁净公布了2025年限制性股票激 ...

Core Insights - Alignment Healthcare reported quarterly earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of a loss of $0.07 per share, and showing improvement from a loss of $0.13 per share a year ago, resulting in an earnings surprise of +200.00% [1] - The company achieved revenues of $1.02 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 5.75%, and compared to revenues of $681.29 million in the same quarter last year [2] Financial Performance - Over the last four quarters, Alignment Healthcare has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $953.68 million, and for the current fiscal year, it is -$0.33 on revenues of $3.8 billion [7] Market Position - Alignment Healthcare shares have increased approximately 4.7% since the beginning of the year, while the S&P 500 has gained 8.3% [3] - The Zacks Industry Rank indicates that the Medical Services sector is currently in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] Future Outlook - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The estimate revisions trend for Alignment Healthcare was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

Core Viewpoint - The U.S. government, under President Trump's leadership, has officially launched a digital health technology ecosystem through the Centers for Medicare & Medicaid Services (CMS) to enhance healthcare experiences for providers, insurers, and software developers [1] Group 1 - The initiative aims to provide tools for healthcare providers, insurance companies, and software developers [1] - The goal is to empower Americans to enjoy advanced health experiences in the 21st century [1]

Core Viewpoint - Meinian Health's stock price closed at 5.04 yuan on July 30, 2025, reflecting a decline of 1.18% from the previous trading day, with a trading volume of 4.35 billion yuan [1] Company Overview - Meinian Health operates in the healthcare services industry, specializing in health check-ups and medical services, including health examinations, health management, and medical consulting [1] Recent Developments - The company has recently received a new business license from the Zhejiang Provincial Market Supervision Administration, following the approval of related amendments by the board of directors and the shareholders' meeting [1] Financial Activity - On July 30, the net inflow of main funds into Meinian Health was 193,400 yuan [1]

GE HealthCare (GEHC) reported second-quarter 2025adjusted earnings per share (EPS) of $1.06, which beat the Zacks Consensus Estimate of 91 cents by 16.5%. Also, the bottom line improved 6% year over year. Key Takeaways GAAP EPS in the quarter was also $1.06, up 13.9% from the year-ago level. Revenue Details The company reported revenues of $5 billion, up 3% year over year on a reported basis and 2% organically. The top line beat the Zacks Consensus Estimate by 0.1%. Total company orders increased 3% organic ...

关于创新医疗管理股份有限公司 上海市锦天城律师事务所 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于创新医疗管理股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受创新医疗管理股份有限 公司（以下简称"公司"或"创新医疗"）委托，就公司召开 2025 年第二次临时 股东会（以下简称"本次股东会"）的有关事宜，根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《上市公司股东会规则》等法律、法规、规章和其他 规范性文件以及《创新医疗管理股份有限公司章程》（以下简称"《公司章程》"） 的有关规定，出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东会所涉及的相关事项 进行了必要的核查和验证，核查了本所认为出具该法律意见书所需的相关文件、 资料，并参加了公司本 ...